$VREX

Five Months After a $490 Million Refinancing, Utah’s Varex Imaging Agrees to be Acquired by Teledyne in a $1.1 Billion Deal

Varex Imaging (NASDAQ:VREX) agreed to be acquired by Teledyne Technologies (NYSE:TDY) for $18.90 per share in a cash deal valued at about $1.1 billion, including Varex equity awards and net debt. Boards approved; close expected early 2027 after shareholder and regulatory approvals. Varex completed a $490 million refinancing in March 2026.

Original reporting
Published Aug 13, 2026, 4:34 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 11:15 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Five Months After a $490 Million Refinancing, Utah’s Varex Imaging Agrees to be Acquired by Teledyne in a $1.1 Billion Deal — source image
Decision brief

The 30-second read

$VREXBullishHigh
01

Why it matters

The primary tradable development is the announced cash offer ($18.90/share) and deal terms (termination fee, financing not contingent), which set merger-arb pricing and define upcoming catalysts (proxy filing, shareholder vote, regulatory clearance).

02

Market read

A disclosed, all-cash acquisition with a stated premium and defined next steps (proxy and approvals) is a direct input to deal-spread and probability-weighted valuation models.

03

What to watch

Proxy statement details (when talks began, whether other bidders emerged, board rationale) can materially change perceived deal certainty and the implied probability-weighted value.

Relevance 10/10Novelty 9/10Timing: deal announced Aug 13, 2026, with proxy statement and early-2027 close as next milestones

Background

Varex completed a $490 million refinancing in March 2026, then agreed to a Teledyne acquisition in August 2026, with closing expected in early 2027.

Company-level read

Ticker impact

$VREXBullishHigh confidence
Context

Varex agreed to be acquired by Teledyne for $18.90 per share in a cash deal valued around $1.1 billion, subject to approvals.

Expected impact

Bullish bias while deal certainty rises; volatility likely around proxy filing, vote timing, and any regulatory feedback.

Evidence & confidence

The article discloses a specific per-share cash offer, premium context, and key deal terms (termination fee, financing not a condition), which directly drive merger-arb and risk pricing.

$TDYBullishMedium confidence
Context

Teledyne will acquire Varex for $18.90 per share, expanding its X-ray detector and photon-counting capabilities via a roughly $1.1 billion transaction.

Expected impact

Moderately positive, with upside tied to deal closing and downside tied to regulatory or integration concerns.

Evidence & confidence

The article provides deal price and strategic fit, but does not quantify accretion, synergies, or detailed financial impact beyond transaction value.

Market effects

Signals consolidation in medical/industrial imaging components (X-ray tubes, detectors, photon counting), potentially reshaping competitive positioning.

Utah-based Varex becomes part of a California-based Teledyne platform, with potential local supply-chain and employment sentiment effects.

Strengthens Teledyne’s global imaging footprint and product breadth, which can influence customer qualification cycles and competitor roadmaps.

Counterpoint

The article notes no evidence the March 2026 refinancing was done in preparation for a sale, so the deal could still face timing or process risk revealed only in the proxy.

Key entities

  • Varex Imaging

    NASDAQ-listed imaging components company agreeing to be acquired for $18.90 per share in cash.

  • Teledyne Technologies

    Acquirer planning to purchase Varex for about $1.1 billion total transaction value, subject to approvals.

  • Zions Bancorporation

    Lead arranger and sole bookrunner for Varex’s March 2026 $490 million refinancing.

  • Evercore

    Financial advisor to Varex, providing an opinion that $18.90 per share is fair from a financial point of view.

Related articles

$TDYMedAI 9/10

Why Is Teledyne Technologies (TDY) Paying a 52% Premium for Varex (VREX)?

Teledyne Technologies (NYSE:TDY) agreed to acquire Varex Imaging (NASDAQ:VREX) for $18.90 per share in cash, a 52% premium to Varex’s unaffected close. The deal values Varex at about $1.1 billion including equity awards and net debt. Varex jumped 48.5% to $18.42 on Aug. 10; TDY fell slightly. Teledyne cited synergies but did not quantify EPS accretion.

$TDYHighAI 10/10

Teledyne to Acquire Varex Imaging Corporation

Teledyne Technologies agreed to acquire Varex Imaging in a cash deal for $18.90 per Varex share, valuing the transaction at about $1.1 billion including equity awards and net debt as of April 3, 2026. Boards approved unanimously. Closing is expected in early 2027, pending regulatory and Varex stockholder approvals.

$TDYMed

Fitch upgrades Teledyne Technologies rating on strong cash flow

Fitch Ratings upgraded Teledyne Technologies Inc. (NYSE:TDY) long-term issuer default rating to BBB+ from BBB and raised its senior unsecured revolver and notes to BBB+ from BBB, with a Stable outlook. Fitch cited stronger free cash flow, low 2.0x EBITDA leverage, debt near $2.0B, and funded backlog about $5.0B. Fitch also referenced TDY’s $1.1B acquisition of Varex Imaging.

$VREXMed

Varex Imaging Corporation revenues hit USD 211M in Q3FY26

Varex Imaging reported unaudited Q3 FY2026 results: revenue of $211 million, GAAP gross margin 36% (non-GAAP 37%), GAAP operating margin 11% (non-GAAP 12%), and GAAP diluted EPS $0.37 (non-GAAP $0.31). Third-quarter revenues rose 4% YoY, with Medical $134 million and Industrial $77 million. The company received $17 million in U.S. Customs refunds tied to IEEPA tariffs.

$VREXMed

Varex Q3 FY2026 Results Show Revenue Growth and Margin Expansion Ahead of Teledyne Transaction

Varex Imaging (NASDAQ:VREX) reported Q3 FY2026 revenue of $211 million, up 4% year over year, with Industrial revenue at $77 million and Medical at $134 million. Non-GAAP gross margin rose to 37% from 34% and non-GAAP EPS increased to $0.31 from $0.13. Tariff refunds and customer reimbursements added about $10 million to gross profit. Varex cancelled its earnings call and declined guidance due to a pending Teledyne Technologies transaction.